The UK Medicinal Cannabis Market Continues to Grow, Notes Ananda Developments – Benzinga
LONDON, June 30, 2020 /PRNewswire/ — Medicinal cannabis continues to get traction in the UK, with the launch by Sapphire Clinics of reduced appointment costs for patients contributing to the UK’s real-world evidence base. This is a welcome initiative to increase the number of patients who can get access to medicinal cannabis. Ananda continues to work towards gaining its licence to grow medicinal cannabis in the UK.
If you would like further information on Ananda’s initiatives and progress please contact Melissa Sturgess, Ananda’s CEO, on email@example.com.
The Directors of the Company accept responsibility for the contents of this announcement.
ANANDA DEVELOPMENTS PLC
Chief Executive Officer
PETERHOUSE CAPITAL LIMTED
SOURCE Ananda Developments Plc
This article originally appeared here in https://www.benzinga.com/pressreleases/20/06/n16443458/the-uk-medicinal-cannabis-market-continues-to-grow-notes-ananda-developments